Robeco Institutional Asset Management B.V. decreased its position in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 75.0% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 27,784 shares of the company’s stock after selling 83,546 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Nu Skin Enterprises were worth $1,330,000 at the end of the most recent quarter.
Several other hedge funds have also recently bought and sold shares of NUS. Norges Bank bought a new position in shares of Nu Skin Enterprises during the 4th quarter worth $56,136,000. BlackRock Inc. grew its stake in shares of Nu Skin Enterprises by 3.4% during the 4th quarter. BlackRock Inc. now owns 6,273,298 shares of the company’s stock worth $384,741,000 after acquiring an additional 205,481 shares during the period. Canada Pension Plan Investment Board grew its stake in shares of Nu Skin Enterprises by 54.6% during the 4th quarter. Canada Pension Plan Investment Board now owns 401,447 shares of the company’s stock worth $24,619,000 after acquiring an additional 141,800 shares during the period. Los Angeles Capital Management & Equity Research Inc. grew its stake in shares of Nu Skin Enterprises by 28.2% during the 1st quarter. Los Angeles Capital Management & Equity Research Inc. now owns 544,400 shares of the company’s stock worth $26,055,000 after acquiring an additional 119,730 shares during the period. Finally, D. E. Shaw & Co. Inc. grew its stake in shares of Nu Skin Enterprises by 34.9% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 444,419 shares of the company’s stock worth $27,256,000 after acquiring an additional 115,021 shares during the period. Institutional investors own 74.80% of the company’s stock.
NUS has been the subject of several research reports. ValuEngine downgraded Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research note on Friday, February 8th. Zacks Investment Research upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating and set a $75.00 price target for the company in a research note on Tuesday, February 12th. Pivotal Research reiterated a “buy” rating and set a $85.00 price target on shares of Nu Skin Enterprises in a research note on Wednesday, February 13th. TheStreet downgraded Nu Skin Enterprises from a “b” rating to a “c+” rating in a research note on Thursday, February 14th. Finally, Citigroup set a $86.00 price objective on Nu Skin Enterprises and gave the stock a “buy” rating in a report on Friday, February 15th. Three research analysts have rated the stock with a sell rating, one has assigned a hold rating and six have assigned a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $73.75.
Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings data on Tuesday, April 30th. The company reported $0.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.71 by $0.06. The business had revenue of $623.60 million for the quarter, compared to analysts’ expectations of $615.98 million. Nu Skin Enterprises had a return on equity of 26.81% and a net margin of 4.82%. The firm’s quarterly revenue was up 1.2% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.79 EPS. As a group, research analysts expect that Nu Skin Enterprises, Inc. will post 3.92 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 12th. Investors of record on Friday, May 31st will be issued a dividend of $0.37 per share. The ex-dividend date is Thursday, May 30th. This represents a $1.48 dividend on an annualized basis and a yield of 2.90%. Nu Skin Enterprises’s dividend payout ratio (DPR) is 42.05%.
ILLEGAL ACTIVITY NOTICE: “Robeco Institutional Asset Management B.V. Cuts Stake in Nu Skin Enterprises, Inc. (NUS)” was first published by Baseball Daily News and is owned by of Baseball Daily News. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The original version of this news story can be viewed at https://www.baseballdailydigest.com/news/2019/05/19/robeco-institutional-asset-management-b-v-cuts-stake-in-nu-skin-enterprises-inc-nus.html.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.
Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS).
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.